Andersen RF - Search Results

1

Carboplatin re-treatment in platinum-resistant epithelial ovarian cancer patients.

Hansen MKG, Smerdel MP, Waldstrøm M, Andersen RF, Adimi P, Jakobsen A, Steffensen KD. Hansen MKG, et al. Among authors: andersen rf. Cancer Chemother Pharmacol. 2020 Dec;86(6):751-759. doi: 10.1007/s00280-020-04162-5. Epub 2020 Oct 16. Cancer Chemother Pharmacol. 2020. PMID: 33067703 Clinical Trial.

2

Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.

Steffensen KD, Waldstrøm M, Andersen RF, Olsen DA, Jeppesen U, Knudsen HJ, Brandslund I, Jakobsen A. Steffensen KD, et al. Among authors: andersen rf. Int J Oncol. 2008 Jul;33(1):195-204. Int J Oncol. 2008. PMID: 18575766

3

The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer.

Garm Spindler KL, Pallisgaard N, Rasmussen AA, Lindebjerg J, Andersen RF, Crüger D, Jakobsen A. Garm Spindler KL, et al. Among authors: andersen rf. Ann Oncol. 2009 May;20(5):879-84. doi: 10.1093/annonc/mdn712. Epub 2009 Jan 29. Ann Oncol. 2009. PMID: 19179548 Free article.

4

Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer.

Smerdel MP, Waldstrøm M, Brandslund I, Steffensen KD, Andersen RF, Jakobsen A. Smerdel MP, et al. Among authors: andersen rf. Int J Gynecol Cancer. 2009 May;19(4):578-84. doi: 10.1111/IGC.0b013e3181a13168. Int J Gynecol Cancer. 2009. PMID: 19509553

5

EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

Spindler KG, Andersen RF, Jensen LH, Ploen J, Jakobsen A. Spindler KG, et al. Among authors: andersen rf. Ann Oncol. 2010 Mar;21(3):535-539. doi: 10.1093/annonc/mdp336. Epub 2009 Oct 22. Ann Oncol. 2010. PMID: 19850635 Free article.

6

The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer.

Hansen TF, Spindler KL, Lorentzen KA, Olsen DA, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A. Hansen TF, et al. Among authors: andersen rf. J Cancer Res Clin Oncol. 2010 May;136(5):751-8. doi: 10.1007/s00432-009-0714-1. Epub 2009 Nov 11. J Cancer Res Clin Oncol. 2010. PMID: 19904558

7

The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer.

Hansen TF, Garm Spindler KL, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A. Hansen TF, et al. Among authors: andersen rf. Pharmacogenomics J. 2011 Feb;11(1):53-60. doi: 10.1038/tpj.2010.4. Epub 2010 Feb 2. Pharmacogenomics J. 2011. PMID: 20125120

8

Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer.

Hansen TF, Sørensen FB, Spindler KL, Olsen DA, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A. Hansen TF, et al. Among authors: andersen rf. Virchows Arch. 2010 Mar;456(3):251-60. doi: 10.1007/s00428-009-0878-8. Epub 2010 Feb 9. Virchows Arch. 2010. PMID: 20143086

9

Quantitative analysis of vascular endothelial growth factor receptors 1 and 2 in colorectal cancer.

Hansen TF, Garm Spindler KL, Lorentzen KA, Olsen DA, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A. Hansen TF, et al. Among authors: andersen rf. Mol Med Rep. 2009 Sep-Oct;2(5):787-92. doi: 10.3892/mmr_00000173. Mol Med Rep. 2009. PMID: 21475902

10

The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer: results from the Nordic ACT trial.

Hansen TF, Christensen Rd, Andersen RF, Garm Spindler KL, Johnsson A, Jakobsen A. Hansen TF, et al. Among authors: andersen rf. Int J Colorectal Dis. 2012 Jun;27(6):715-20. doi: 10.1007/s00384-011-1382-6. Epub 2011 Dec 6. Int J Colorectal Dis. 2012. PMID: 22139032 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page